Register entry
- Registered sites
- 0
- Active NDC listings
- 5
- Labeller names
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
55 active NDC listings: 5 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 5.
| Dosage form | NDCs |
|---|---|
| capsule | 5 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| catalent france beinheim sa | 3 |
| catalent france beinheim s.a | 1 |
| catalent france beinheim s.a. | 1 |
Catalogue
Marketed products
5| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Isotretinoin | capsule | 64566-0003DRUG FOR FURTHER PROCESSING |
| - | Isotretinoin | capsule | 64566-0004DRUG FOR FURTHER PROCESSING |
| - | Isotretinoin | capsule | 64566-0016DRUG FOR FURTHER PROCESSING |
| - | Tretinoin | capsule | 64566-0009DRUG FOR FURTHER PROCESSING |
| - | isotretinoin | capsule | 64566-0014DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing isotretinoin
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Zydus Lifesciences Limited12 sites · 717 NDC
- Olon USA LLC11 sites · 185 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Teva Pharmaceutical Industries Ltd.6 sites · 668 NDC
- Hetero Drugs Limited4 sites · 133 NDC
- Chongqing Huapont Pharmaceutical Co Ltd2 sites · 10 NDC
- Zydus Pharmaceuticals USA Inc.1 site · 626 NDC
- Amneal Ireland Limited1 site · 513 NDC
- Actavis LLC1 site · 309 NDC
Enquiry
Common questions
- Is Catalent France Beinheim S.A. FDA approved?
- Catalent France Beinheim S.A. holds no registered establishment of its own; 5 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Catalent France Beinheim S.A. make?
- 5 products are listed under Catalent France Beinheim S.A. in the openFDA NDC Directory, most often as capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.